Rezultati pretraživanja
  1. Great to be invited to important meeting on with leading experts

  2. 9. sij

    RT: The call for abstracts for 2020 ISSDP conference in Aguascalientes has been extended until 17 Jan 2020. Submit your abstract today:

  3. 16. sij 2017.
  4. Coronary stents added in NLEM, 2015 and their ceiling prices fixed, providing relief to patients.

  5. Ppl are quick to point to reasons why we shouldn’t rush into policy demands of , , , or BUT those same ppl ignore the actual costs of a slow learning curve - this isn’t about what makes you comfortable it’s about what saves lives

    Prikaži ovu nit
  6. 19. stu 2019.

    Is fecal microbiome samples for transplantation a tissue or a drug? Interesting talk by Christian Hvaas from Aarhus at the 6th National Microbiota Conference

  7. New National List of Essential Medicines (NLEM, 2015) finalized, which now includes 376 medicines.

  8. Medical Device Rules 2017 to provide for risk-based classification, licensing & medical device regulation

  9. Rs. 1,750-Crore worth scheme has been approved for strengthening drug regulatory structures in India.

  10. Interesting talk at by Dr. Dal Pan from the on drug safety label changes over time

  11. 8. ožu 2019.

    Learning about the history of from at - Such an exciting time to be an

  12. 4. pro 2016.

    Legislation that would streamline at the and at the is one step closer to becoming law

  13. Clinical Trial approval process simplified to ensure ease of doing business.

  14. 8. ožu 2019.

    speaking at on the regulatory aspects of drug approvals. Thanks to all the Oncology Fellows who came out to this event! Visit for info on use

  15. The American Condition: Cancer drug prices in other countries are 50-80% less in any other country. Same drug.

  16. 4. sij 2017.
  17. 23. velj 2017.

    @ema2cph begins battle for : "Objective criteria are a must" ($)

  18. 28. stu 2017.

    Another industry struggles with regulation pressure. It’s a data integration problem - Manufacturers and Trading Partners Struggle to Meet Drug Tracking Requirements

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.